Tokyo, Jan. 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060300) titled 'Randomized study of effects of magnesium-rich water on Laxation in healthy subjects' on Jan. 8.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Single blind -participants are blinded
Control - No treatment
Primary Sponsor:
Institute - Hyogo Medical University
Condition:
Condition - Healthy subjects
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To assess the effects of magnesium-rich water on Laxation in health subjects
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - soft water
Interventions/Control_2 - hard water(Magnesium rich water)
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male and Female
Key inclusion criteria - Individuals who do not meet the diagnostic criteria for constipation or irritable bowel syndrome.
This also includes those undergoing treatment for mild chronic conditions (e.g., hypertension, dyslipidemia)."
Key exclusion criteria - 1. Individuals who meet the Rome IV criteria for constipation or irritable bowel syndrome.
Target Size - 60
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 06 Month 24 Day
Date of IRB - 2025 Year 07 Month 03 Day
Anticipated trial start date - 2025 Year 07 Month 04 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066724
Disclaimer: Curated by HT Syndication.
